Arie Belldegrun - Insider Trading & Ownership

Location
Ucla School Of Medicine, 10833 Le Conte 66 118 Chs Box 951738, Los Angeles, CA
Summary
The estimated net worth of Arie Belldegrun is at least $12.8M dollars as of August 27, 2025. Arie Belldegrun is the Director of Allogene Therapeutics, Inc. and owns shares of Allogene Therapeutics, Inc. (ALLO) stock worth about $12.2M. Arie Belldegrun is the Director of Ginkgo Bioworks Holdings, Inc. and owns shares of Ginkgo Bioworks Holdings, Inc. (DNA) stock worth about $619K.
Signature
/s/ Jason D. Smith, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Arie Belldegrun

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ALLO Allogene Therapeutics, Inc. Director $12.2M Jan 24, 2025
DNA, DNABW Ginkgo Bioworks Holdings, Inc. Director $619K Jun 12, 2024
KRON Kronos Bio, Inc. Director $0 Jun 20, 2025
URGN UroGen Pharma Ltd. Director Aug 26, 2025

Insider Transactions Reported by Arie Belldegrun:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.